Illumina Certifies Asuragen and DeCode as BeadChip Service Providers | GenomeWeb
This article has been updated from a previous version, which incorrectly identified Asuragen as an ABI subsidiary. The details of ABI's acquisition of Ambion have also been corrected. 
NEW YORK (GenomeWeb News) — Illumina today said it has certified Asuragen as a gene expression profiling services provider for its Human-6 Expression BeadChip.
Illumina has also certified DeCode Genetics to use its Infinium BeadChip genotyping platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.